{"id":"W2088460013","doi":"10.1007/s10637-014-0082-9","title":"Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Rash; Internal medicine; Cancer; Adverse effect; Pharmacodynamics; Breast cancer; Oncology; Tolerability; Phases of clinical research; Colorectal cancer; Clinical trial; Gastroenterology; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001997955,0.0001853241,0.0002104069,0.00008207803,0.00005513482,0.00002021767,0.0001220561,0.00009356335,0.000005812985],"category_scores_gemma":[0.0001034273,0.0001719314,0.00002111927,0.0001558251,0.0001318307,0.00003576273,0.00005387871,0.0001009546,0.000001196991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003041808,"about_ca_system_score_gemma":0.0002038213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001302451,"about_ca_topic_score_gemma":0.0001409978,"domain_scores_codex":[0.998553,0.0001201559,0.0003629813,0.0004251549,0.0003613275,0.0001773212],"domain_scores_gemma":[0.9991944,0.00002737264,0.0002039013,0.0002514329,0.0001683247,0.00015459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001868044,0.003384787,0.4596075,0.00005806112,0.00008185893,0.000002075337,0.002267598,0.008666178,0.4879538,0.000218829,0.0005894423,0.03530182],"study_design_scores_gemma":[0.034571,0.01680435,0.7259006,0.0002549038,0.00006336079,0.000003024565,0.0005248601,0.003477629,0.2150441,0.00160081,0.0009042688,0.0008511006],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991876,0.00003207468,0.000150605,0.00006978363,0.00008611647,0.0003972122,0.00001672633,0.00001250399,0.00004730444],"genre_scores_gemma":[0.9980095,0.000002238059,0.001234765,0.0001940317,0.0001436106,0.00002457949,0.0003358784,0.00002664646,0.00002873914],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2729097,"threshold_uncertainty_score":0.701116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009291892874384198,"score_gpt":0.2711400666733916,"score_spread":0.2618481737990074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}